A sample of projects by therapeutic area
Multi-condition, multi-geography, 100% patient-centric
  TA |
 Indication |
 Examples |
|---|---|---|
| Oncology |
Melanoma | Multi-year registry study |
| Breast Cancer | Emerging markets breast cancer RWE study | |
| Multiple Myeloma | Patient Support Program for top 20 pharma | |
| CNS |
Parkinson’s | 4,200 participant direct-to-patient study |
| Multiple Sclerosis | Web-based eConsent platform for multi-country study | |
| Multiple Sclerosis | Patient Support Program for top 20 pharma | |
| Respiratory / Allergy |
Asthma | Symptom tracking to show subtle difference in patient quality of life not apparent on a standard quality of life questionnaire |
| COVID-19 | Virtual study looking at effectiveness of sinus wash to reduce transmission of COVID-19 | |
| Cardiovascular / Endocrinology |
Diabetes | Continuous glucose monitoring and activity tracking with real-time symptom reporting and patient reported outcomes (PROs) in 5 countries |
| Heart Failure | Multiple studies supporting One Brave Idea heart failure program | |
| Heart Failure | Symptom and questionnaire data capture correlated with Med device data for heart failure occurrence post hospital discharge | |
| Dermatology |
Eczema | Multi-country observational study |
| Atopic Dermatitis | 12 European country Phase Ila for a top 20 pharma | |
| Immunology and Inflammation |
Rheumatoid Arthritis | 13,500 participant direct-to patient study into the link between weather and pain |
| Rheumatoid Arthritis | Virtual study linking symptoms, validated questionnaire, and bloodspot data | |
| Rheumatoid Arthritis | Virtual study linking symptoms, validated questionnaire, and wearable device sleep data | |
| Rare disease |
Dravet Syndrome | Observational study investigating caregiver burden for children with Dravet Syndrome |
| Haemophilia | Global haemophilia patient support program (commercial) for a top 20 pharma | |
| Haemophilia | Multi-study PIV and Observational program across 26 countries for top 5 Pharma | |
| Glioblastoma | OurBrainBank – patient-led movement allowing patients with GBM to track symptoms to help accelerate new treatments to market |